BioCentury | Sep 27, 2017
Distillery Therapeutics

Infectious disease

...death of 12 days post-challenge in 6 of 6 animals. Next steps in collaboration with Zalgen Labs LLC...
...arenaviruses, in preclinical development. TARGET/MARKER/PATHWAY: Lassa virus glycoprotein LICENSING STATUS: Patent application filed; licensed to Zalgen Labs LLC...
...Robert F. Garry, Tulane University, New Orleans, La. email: rfgarry@tulane.edu Elizabeth S. Eaton Tulane University School of Medicine Zalgen Labs LLC Lassa...
BioCentury | Sep 6, 2017
Preclinical News

Human mAbs could treat Lassa fever

...published in Nature Medicine , researchers at the University of Texas , Tulane University and Zalgen Labs LLC...
...preclinical development (see BioCentury Innovations, June 30, 2016) . Elizabeth S. Eaton GEO-LM01 LHF-535 GeoVax Labs Inc. Kineta Inc. Orgentec Diagnostika GmbH Zalgen Labs LLC...
BioCentury | Sep 5, 2016
Company News

Corgenix Medical Corp., Zalgen Labs deal

...are not disclosed. Corgenix did not respond to inquiries. Corgenix Medical Corp. , Broomfield, Colo. Zalgen Labs LLC...
BioCentury | Jan 15, 2015
Finance

Consortia cross-talk

...Viral Hemorrhagic Fever Immunotherapeutic Consortium Cangene Corp. (TSX:CNJ); Emergent BioSolutions Inc. (NYSE:EBS); Mapp Biopharmaceutical Inc.; Zalgen Labs LLC...
BioCentury | May 29, 2014
Strategy

New York's biotech beginnings

...neutralizing antibodies against HIV-1 $9.8 million March 2014 Emergent BioSolutions Inc. (NYSE:EBS); Mapp Biopharmaceutical Inc.; Zalgen Labs LLC...
BioCentury | Apr 17, 2014
Translation in Brief

Translational tidbits

...Archives Companies Institutions Business area Disclosed value Purpose Emergent BioSolutions Inc. (NYSE:EBS); Mapp Biopharmaceutical Inc.; Zalgen Labs LLC...
BioCentury | Mar 31, 2014
Company News

Emergent BioSolutions, Mapp Biopharmaceutical, Zalgen Labs, Ben-Gurion University of the Negev, NIH, Public Health Agency of Canada, Scripps Research Institute,

...March 3). Emergent BioSolutions Inc. (NYSE:EBS), Rockville, Md. Mapp Biopharmaceutical Inc. , San Diego, Calif. Zalgen Labs LLC...
BioCentury | Nov 25, 2013
Company News

Corgenix Medical Corp., Zalgen Labs deal

...are not disclosed, and Zalgen could not be reached. Corgenix Medical Corp. (OTCBB:CONX), Broomfield, Colo. Zalgen Labs LLC...
Items per page:
1 - 8 of 8
BioCentury | Sep 27, 2017
Distillery Therapeutics

Infectious disease

...death of 12 days post-challenge in 6 of 6 animals. Next steps in collaboration with Zalgen Labs LLC...
...arenaviruses, in preclinical development. TARGET/MARKER/PATHWAY: Lassa virus glycoprotein LICENSING STATUS: Patent application filed; licensed to Zalgen Labs LLC...
...Robert F. Garry, Tulane University, New Orleans, La. email: rfgarry@tulane.edu Elizabeth S. Eaton Tulane University School of Medicine Zalgen Labs LLC Lassa...
BioCentury | Sep 6, 2017
Preclinical News

Human mAbs could treat Lassa fever

...published in Nature Medicine , researchers at the University of Texas , Tulane University and Zalgen Labs LLC...
...preclinical development (see BioCentury Innovations, June 30, 2016) . Elizabeth S. Eaton GEO-LM01 LHF-535 GeoVax Labs Inc. Kineta Inc. Orgentec Diagnostika GmbH Zalgen Labs LLC...
BioCentury | Sep 5, 2016
Company News

Corgenix Medical Corp., Zalgen Labs deal

...are not disclosed. Corgenix did not respond to inquiries. Corgenix Medical Corp. , Broomfield, Colo. Zalgen Labs LLC...
BioCentury | Jan 15, 2015
Finance

Consortia cross-talk

...Viral Hemorrhagic Fever Immunotherapeutic Consortium Cangene Corp. (TSX:CNJ); Emergent BioSolutions Inc. (NYSE:EBS); Mapp Biopharmaceutical Inc.; Zalgen Labs LLC...
BioCentury | May 29, 2014
Strategy

New York's biotech beginnings

...neutralizing antibodies against HIV-1 $9.8 million March 2014 Emergent BioSolutions Inc. (NYSE:EBS); Mapp Biopharmaceutical Inc.; Zalgen Labs LLC...
BioCentury | Apr 17, 2014
Translation in Brief

Translational tidbits

...Archives Companies Institutions Business area Disclosed value Purpose Emergent BioSolutions Inc. (NYSE:EBS); Mapp Biopharmaceutical Inc.; Zalgen Labs LLC...
BioCentury | Mar 31, 2014
Company News

Emergent BioSolutions, Mapp Biopharmaceutical, Zalgen Labs, Ben-Gurion University of the Negev, NIH, Public Health Agency of Canada, Scripps Research Institute,

...March 3). Emergent BioSolutions Inc. (NYSE:EBS), Rockville, Md. Mapp Biopharmaceutical Inc. , San Diego, Calif. Zalgen Labs LLC...
BioCentury | Nov 25, 2013
Company News

Corgenix Medical Corp., Zalgen Labs deal

...are not disclosed, and Zalgen could not be reached. Corgenix Medical Corp. (OTCBB:CONX), Broomfield, Colo. Zalgen Labs LLC...
Items per page:
1 - 8 of 8